Northwest & Ethical Investments L.P. Royalty Pharma PLC Transaction History
Northwest & Ethical Investments L.P.
- $3.79 Trillion
- Q3 2024
A detailed history of Northwest & Ethical Investments L.P. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 27,746 shares of RPRX stock, worth $704,748. This represents 0.02% of its overall portfolio holdings.
Number of Shares
27,746
Previous 27,746
-0.0%
Holding current value
$704,748
Previous $785 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
413Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.04 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$955 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$585 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$410 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$307 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...